231 related articles for article (PubMed ID: 10766763)
1. Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element.
Pagani F; Buratti E; Stuani C; Romano M; Zuccato E; Niksic M; Giglio L; Faraguna D; Baralle FE
J Biol Chem; 2000 Jul; 275(28):21041-7. PubMed ID: 10766763
[TBL] [Abstract][Full Text] [Related]
2. An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing.
Zuccato E; Buratti E; Stuani C; Baralle FE; Pagani F
J Biol Chem; 2004 Apr; 279(17):16980-8. PubMed ID: 14966131
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9.
Niksic M; Romano M; Buratti E; Pagani F; Baralle FE
Hum Mol Genet; 1999 Dec; 8(13):2339-49. PubMed ID: 10556281
[TBL] [Abstract][Full Text] [Related]
4. A T3 allele in the CFTR gene exacerbates exon 9 skipping in vas deferens and epididymal cell lines and is associated with Congenital Bilateral Absence of Vas Deferens (CBAVD).
Disset A; Michot C; Harris A; Buratti E; Claustres M; Tuffery-Giraud S
Hum Mutat; 2005 Jan; 25(1):72-81. PubMed ID: 15580565
[TBL] [Abstract][Full Text] [Related]
5. Promoter architecture modulates CFTR exon 9 skipping.
Pagani F; Stuani C; Zuccato E; Kornblihtt AR; Baralle FE
J Biol Chem; 2003 Jan; 278(3):1511-7. PubMed ID: 12421814
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a disease-associated mutation affecting a putative splicing regulatory element in intron 6b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Faà V; Incani F; Meloni A; Corda D; Masala M; Baffico AM; Seia M; Cao A; Rosatelli MC
J Biol Chem; 2009 Oct; 284(44):30024-31. PubMed ID: 19759008
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous spectrum of mutations in CFTR gene from Indian patients with congenital absence of the vas deferens and their association with cystic fibrosis genetic modifiers.
Sharma H; Mavuduru RS; Singh SK; Prasad R
Mol Hum Reprod; 2014 Sep; 20(9):827-35. PubMed ID: 24958810
[TBL] [Abstract][Full Text] [Related]
8. Molecular study of (TG)m(T)n polymorphisms in Iranian males with congenital bilateral absence of the vas deferens.
Radpour R; Gourabi H; Gilani MA; Dizaj AV
J Androl; 2007; 28(4):541-7. PubMed ID: 17314234
[TBL] [Abstract][Full Text] [Related]
9. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping.
Buratti E; Dörk T; Zuccato E; Pagani F; Romano M; Baralle FE
EMBO J; 2001 Apr; 20(7):1774-84. PubMed ID: 11285240
[TBL] [Abstract][Full Text] [Related]
10. SR protein-mediated inhibition of CFTR exon 9 inclusion: molecular characterization of the intronic splicing silencer.
Buratti E; Stuani C; De Prato G; Baralle FE
Nucleic Acids Res; 2007; 35(13):4359-68. PubMed ID: 17576688
[TBL] [Abstract][Full Text] [Related]
11. Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene.
Aznarez I; Chan EM; Zielenski J; Blencowe BJ; Tsui LC
Hum Mol Genet; 2003 Aug; 12(16):2031-40. PubMed ID: 12913074
[TBL] [Abstract][Full Text] [Related]
12. A variable dinucleotide repeat in the CFTR gene contributes to phenotype diversity by forming RNA secondary structures that alter splicing.
Hefferon TW; Groman JD; Yurk CE; Cutting GR
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3504-9. PubMed ID: 14993601
[TBL] [Abstract][Full Text] [Related]
13. Missense, nonsense, and neutral mutations define juxtaposed regulatory elements of splicing in cystic fibrosis transmembrane regulator exon 9.
Pagani F; Buratti E; Stuani C; Baralle FE
J Biol Chem; 2003 Jul; 278(29):26580-8. PubMed ID: 12732620
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance.
Buratti E; Brindisi A; Pagani F; Baralle FE
Am J Hum Genet; 2004 Jun; 74(6):1322-5. PubMed ID: 15195661
[No Abstract] [Full Text] [Related]
15. Functional properties and evolutionary splicing constraints on a composite exonic regulatory element of splicing in CFTR exon 12.
Haque A; Buratti E; Baralle FE
Nucleic Acids Res; 2010 Jan; 38(2):647-59. PubMed ID: 19910374
[TBL] [Abstract][Full Text] [Related]
16. Rescue of common exon-skipping mutations in cystic fibrosis with modified U1 snRNAs.
Donegà S; Rogalska ME; Pianigiani G; Igreja S; Amaral MD; Pagani F
Hum Mutat; 2020 Dec; 41(12):2143-2154. PubMed ID: 32935393
[TBL] [Abstract][Full Text] [Related]
17. R117H and IVS8-5T cystic fibrosis mutation detection by restriction enzyme digestion.
Shrimpton AE
Mol Diagn; 2000 Sep; 5(3):235-8. PubMed ID: 11070158
[TBL] [Abstract][Full Text] [Related]
18. Alternative splicing of intron 23 of the human cystic fibrosis transmembrane conductance regulator gene resulting in a novel exon and transcript coding for a shortened intracytoplasmic C terminus.
Yoshimura K; Chu CS; Crystal RG
J Biol Chem; 1993 Jan; 268(1):686-90. PubMed ID: 7678008
[TBL] [Abstract][Full Text] [Related]
19. Exon identity influences splicing induced by exonic variants and in silico prediction efficacy.
Martin N; Bergougnoux A; Baatallah N; Chevalier B; Varilh J; Baux D; Costes B; Fanen P; Raynal C; Sermet-Gaudelus I; Girodon E; Taulan-Cadars M; Hinzpeter A
J Cyst Fibros; 2021 May; 20(3):464-472. PubMed ID: 33341408
[TBL] [Abstract][Full Text] [Related]
20. CELF proteins regulate CFTR pre-mRNA splicing: essential role of the divergent domain of ETR-3.
Dujardin G; Buratti E; Charlet-Berguerand N; Martins de Araujo M; Mbopda A; Le Jossic-Corcos C; Pagani F; Ferec C; Corcos L
Nucleic Acids Res; 2010 Nov; 38(20):7273-85. PubMed ID: 20631008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
